Ra Capital Management, L.P. - Director at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
MLYS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ra Capital Management, L.P. - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by Ra Capital Management, L.P. for Mineralys Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.28M $57.8M $13.50 Mar 13, 2025 Indirect
Stock Option (Right to Buy) 32.9K Feb 13, 2025 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.